Keywords: CTB, cutaneous tuberculosis; IRIS, immune reconstitution inflammatory syndrome; MTX, methotrexate; MTX-LPD, methotrexate-associated lymphoproliferative disorder; Mycobacterium tuberculosis; TB, tuberculosis; Tac, tacrolimus; cutaneous tuberculosis; methotrexate-associated lymphoproliferative disorder; non-HIV immune reconstitution inflammatory syndrome; tuberculous cellulitis.